Mei Pharma (NASDAQ: MEIP)
$3.25
(-1.8%)
-$0.06
Price as of April 18, 2024, 2:23 p.m. ET
Mei Pharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Mei Pharma Company Info
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its products include Zandelisib, Voruciclib, and ME-344. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.
News & Analysis
Featured Article
Why MEI Pharma Is Tanking 15.3% Today
A trial evaluating its most advanced drug has been discontinued because of a lack of efficacy.
Todd Campbell | Jul 2, 2020
Featured Article
7 Surprising 1-Star Stocks
From the very depths of pessimism come some nice returns.
Matt Koppenheffer | Jan 16, 2007
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.